Cargando…

A Pathology-based Case Series of Influenza- and COVID-19–associated Pulmonary Aspergillosis: The Proof Is in the Tissue

RATIONALE: Invasive pulmonary aspergillosis has emerged as a frequent coinfection in severe coronavirus disease (COVID-19), similarly to influenza, yet the clinical invasiveness is more debated. OBJECTIVES: We investigated the invasive nature of pulmonary aspergillosis in histology specimens of infl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vanderbeke, Lore, Jacobs, Cato, Feys, Simon, Reséndiz-Sharpe, Agustin, Debaveye, Yves, Hermans, Greet, Humblet-Baron, Stephanie, Lagrou, Katrien, Meersseman, Philippe, Peetermans, Marijke, Seldeslachts, Laura, Vanstapel, Arno, Vande Velde, Greetje, Van Wijngaerden, Eric, Wilmer, Alexander, Verbeken, Erik, De Hertogh, Gert, Wauters, Joost
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395719/ https://www.ncbi.nlm.nih.gov/pubmed/37311243 http://dx.doi.org/10.1164/rccm.202208-1570OC

Ejemplares similares

Early oseltamivir reduces risk for influenza-associated aspergillosis in a double-hit murine model
por: Seldeslachts, Laura, et al.
Publicado: (2021)

Longitudinal multimodal imaging-compatible mouse model of triazole-sensitive and -resistant invasive pulmonary aspergillosis
por: Resendiz-Sharpe, Agustin, et al.
Publicado: (2022)

Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study
por: Feys, Simon, et al.
Publicado: (2022)

S3.3d Influenza versus COVID-19-associated pulmonary aspergillosis: Profiling lower respiratory tract epithelial and myeloid innate immunity in patient samples
por: Feys, Simon, et al.
Publicado: (2022)

Overcome Double Trouble: Baloxavir Marboxil Suppresses Influenza Thereby Mitigating Secondary Invasive Pulmonary Aspergillosis
por: Seldeslachts, Laura, et al.
Publicado: (2021)

Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study
por: Wauters, Joost, et al.
Publicado: (2012)

Impact of BMI on outcomes in respiratory ECMO: an ELSO registry study
por: Peetermans, Marijke, et al.
Publicado: (2022)

Powerful and Real-Time Quantification of Antifungal Efficacy against Triazole-Resistant and -Susceptible Aspergillus fumigatus Infections in Galleria mellonella by Longitudinal Bioluminescence Imaging
por: Vanhoffelen, Eliane, et al.
Publicado: (2023)

Rapidly Fatal Acanthamoeba Encephalitis and Treatment of Cryoglobulinemia
por: Meersseman, Wouter, et al.
Publicado: (2007)

Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial
por: Vanderbeke, Lore, et al.
Publicado: (2021)

967. Inhibition of Host Neuraminidase Increases Susceptibility to Invasive Pulmonary Aspergillosis
por: Van De Veerdonk, Frank, et al.
Publicado: (2018)

Quantitative PCR Effectively Quantifies Triazole-Susceptible and Triazole-Resistant Aspergillus fumigatus in Mixed Infections
por: Resendiz-Sharpe, Agustin, et al.
Publicado: (2022)

Atypical response to bacterial coinfection and persistent neutrophilic bronchoalveolar inflammation distinguish critical COVID-19 from influenza
por: Cambier, Seppe, et al.
Publicado: (2022)

Mucorales PCR in blood as an early marker of invasive gastrointestinal mucormycosis might decrease the delay in treatment: A case report
por: Aerts, Robina, et al.
Publicado: (2022)

Aerobic exercise capacity in long-term survivors of critical illness: secondary analysis of the post-EPaNIC follow-up study
por: Van Aerde, Nathalie, et al.
Publicado: (2021)

Severe COVID-19 patients display hyper-activated NK cells and NK cell-platelet aggregates
por: Malengier-Devlies, Bert, et al.
Publicado: (2022)

Neuraminidase and SIGLEC15 modulate the host defense against pulmonary aspergillosis
por: Dewi, Intan M.W., et al.
Publicado: (2021)

A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA)
por: Feys, Simon, et al.
Publicado: (2021)

Severe ARDS due to Ruxolitinib discontinuation syndrome: case presentation and literature review
por: Houthuys, Jona F., et al.
Publicado: (2022)

Increasing Incidence of Mucormycosis in University Hospital, Belgium
por: Saegeman, Veroniek, et al.
Publicado: (2010)

Lung Functioning and Inflammation in a Mouse Model of Systemic Juvenile Idiopathic Arthritis
por: Malengier-Devlies, Bert, et al.
Publicado: (2021)

The impact of extracorporeal membrane oxygenation on the exposure to isavuconazole: a plea for thorough pharmacokinetic evaluation
por: Mertens, Beatrijs, et al.
Publicado: (2022)

External Validation of the Augmented Renal Clearance Predictor in Critically Ill COVID-19 Patients
por: Huang, Chao-Yuan, et al.
Publicado: (2023)

Do Cerebral Cortex Perfusion, Oxygen Delivery, and Oxygen Saturation Responses Measured by Near-Infrared Spectroscopy Differ Between Patients Who Fail or Succeed in a Spontaneous Breathing Trial? A Prospective Observational Study
por: Louvaris, Zafeiris, et al.
Publicado: (2022)

Cerebral cortex and respiratory muscles perfusion during spontaneous breathing attempts in ventilated patients and its relation to weaning outcomes: a protocol for a prospective observational study
por: Louvaris, Zafeiris, et al.
Publicado: (2019)

Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the host
por: Lloréns-Rico, Verónica, et al.
Publicado: (2021)

Concomitant Treatment with Voriconazole and Flucloxacillin: A Combination to Avoid
por: Van Daele, Ruth, et al.
Publicado: (2021)

Successful Multimodal Therapy with Intracerebral Liposomal Amphotericin B and Systemic High-Dose Isavuconazole in Proven Disseminated Aspergillosis
por: Feys, Simon, et al.
Publicado: (2023)

Multinational Observational Cohort Study of COVID-19–Associated Pulmonary Aspergillosis
por: Janssen, Nico A.F., et al.
Publicado: (2021)

Autopsy-detected diagnostic errors in critically ill patients with cirrhosis
por: De Mey, N, et al.
Publicado: (2014)

Invasive aspergillosis in a medical ICU: the spectrum of disease in 89 nonhaematology patients
por: Meersseman, W, et al.
Publicado: (2004)

Isavuconazole in the Treatment of Aspergillus fumigatus Fracture-Related Infection: Case Report and Literature Review
por: Mertens, Beatrijs, et al.
Publicado: (2022)

The soluble mannose receptor (sMR/sCD206) in critically ill patients with invasive fungal infections, bacterial infections or non-infectious inflammation: a secondary analysis of the EPaNIC RCT
por: De Vlieger, Greet, et al.
Publicado: (2019)

Pharmacokinetic Variability and Target Attainment of Fluconazole in Critically Ill Patients
por: Van Daele, Ruth, et al.
Publicado: (2021)

Increased IL‐10‐producing regulatory T cells are characteristic of severe cases of COVID‐19
por: Neumann, Julika, et al.
Publicado: (2020)

Relationship between Abdominal Pressure, Pulmonary Compliance, and Cardiac Preload in a Porcine Model
por: Wauters, Joost, et al.
Publicado: (2012)

From Mouse to Man and Back: Closing the Correlation Gap between Imaging and Histopathology for Lung Diseases
por: Tielemans, Birger, et al.
Publicado: (2020)

CryptoCEST: A promising tool for spatially resolved identification of fungal brain lesions and their differentiation from brain tumors with MRI
por: Vanherp, Liesbeth, et al.
Publicado: (2021)

Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb
por: Khan, Mona, et al.
Publicado: (2021)

PK/PD of single-dose amikacin in emergency department patients with severe sepsis/shock: should we apply the ICU-based higher loading dose?
por: Winter, S De, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_90pcr4tarkfu2idd42gjd6rkl5